Amphotericin B Completed Phase 2 Trials for Pulmonary Invasive Aspergillosis / Leukaemia, Lymphoblastic / Myeloblastic Leukemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01615809Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia